Respiratory depression following epidural morphine in an infant of three months of age

Related Experiment Videos

R Vilà1, E Miguel, N Montferrer

  • 1Department of Anaesthesia, Hospital Infantil Vall d'Hebron, Barcelona, Spain.

Paediatric Anaesthesia
|January 1, 1997
PubMed

Insights

Epidural morphine in infants can cause serious respiratory depression. Naloxone successfully reversed these effects, highlighting the need for specialized monitoring after pediatric epidural opioid use.

Area of Science:

  • Anesthesiology
  • Pediatric Anesthesia
  • Pain Management

Background:

  • Epidural anesthesia combining opioids and local anesthetics is common in pediatric patients.
  • Respiratory depression due to rostral spread of epidural morphine in cerebrospinal fluid (CSF) is a significant concern.

Observation:

  • A three-month-old infant received epidural bupivacaine and morphine for Kasai's operation.
  • Six hours post-administration, the infant exhibited respiratory depression, drowsiness, miosis, and decreased respiratory rate.

Findings:

  • The infant's respiratory depression was confirmed by low SpO2 and blood gas analysis.
  • Intravenous naloxone administration (bolus and infusion) completely reversed the opioid-induced respiratory depression.

Implications:

  • Close monitoring in specialized recovery units is crucial for pediatric patients receiving epidural opioids.
  • This case underscores the importance of prompt recognition and management of respiratory depression following pediatric epidural analgesia.

Related Concept Videos